Loading...

Adicet Bio ($ACET)

ACET Overview

Adicet Bio, a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases.The company offers gamma delta T cells engineered with chimeric antigen receptors or T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.Its products pipeline includes ADI-001, which is in Phase 1 clinical study to treat non-Hodgkin's lymphoma; and ADI-002 that is in Phase 1 clinical study for the treatment of hepatocellular carcinoma and other solid tumors.The company is based in Menlo Park, California. (From: StockAnalysis.com)

MORE ABOUT Adicet Bio

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.

CONVERSATIONS ABOUT Adicet Bio